Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients Following Acute Coronary Syndromes: From Lipid Lowering and Plaque Stabilization to Improved Outcomes
Article in Journal of Clinical Medicine (August 2024)
The most recent citing publications are shown below. View all 8 publications that cite this research output on Dimensions.
Article in Journal of Clinical Medicine (August 2024)
Article in European Journal of Clinical Investigation (May 2024)
Article in Frontiers in Pharmacology (January 2024)